Ellevest Inc’s Mirum Pharmaceuticals MIRM Stock Holding History

Ellevest Inc’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8	Closed	–	–	1918
2022 Q3	$0	Sell	8 -74	-90%	-$1.78K	﹤0.01%	1758
2022 Q2	$2K	Buy	+82	New	+$1.93K	﹤0.01%	1166

Other funds holding MIRM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

RVM

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Ellevest Inc's MIRM Position: Q4 2022 in Review

Ellevest Inc sold out of Mirum Pharmaceuticals (MIRM) in Q4 2022, closing a stake of 8 shares.

Ellevest Inc first reported a position in MIRM in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 104 funds tracked by Wall St. Rank hold MIRM as of Q4 2022.

Ellevest Inc reported no remaining Mirum Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Ellevest Inc sold 8 Mirum Pharmaceuticals shares in Q4 2022.
Ellevest Inc first reported a position in Mirum Pharmaceuticals in Q2 2022 and held it in 2 quarters.
Ellevest Inc's Mirum Pharmaceuticals position peaked at $2K in Q2 2022.
104 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.